Benign Presentation Following Massive Deutetrabenazine Overdose

Deutetrabenazine (DTBZ) (Austedo®) is a novel vesicular monoamine transporter 2 (VMAT2) inhibitor, which acts by blocking dopamine release and other monoamines from neuronal vesicles. Although this drug is considered the first-line treatment for tardive dyskinesia (TD), VMAT2 inhibition has also bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Obadeyi, Oluseyi, Paxton, James H, Kouyoumjian, Sarkis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Emergency Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899254/
https://www.ncbi.nlm.nih.gov/pubmed/33633914
http://dx.doi.org/10.7759/cureus.12886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899254/
https://www.ncbi.nlm.nih.gov/pubmed/33633914
http://dx.doi.org/10.7759/cureus.12886

Ejemplares similares